Drug addiction, like all psychiatric disorders, is defined solely in behavioural terms. For example, addiction can be considered a loss of control over drug-taking, or compulsive drug-seeking and -taking despite horrendous consequences. Abnormal behaviours are a consequence of aberrant brain function, which means that it is a tangible goal to identify the biological underpinnings of addiction. The genetic basis of addiction encompasses two broad areas of enquiry. One of these is the identification of genetic variation in humans that partly determines susceptibility to addiction. The other is the use of animal models to investigate the role of specific genes in mediating the development of addiction. Whereas recent advances in this latter effort are heartening, a major challenge remains: to understand how the many genes implicated in rodent models interact to yield as complex a phenotype as addiction.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Kendler, K.S. et al. A twin-family study of alcoholism in women. Am. J. Psychiatry 151, 707–715 (1994).
Tsuang, M.T. et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch. Gen. Psychiatry 55, 967–972 (1998).
Kendler, K.S., Karkowski, L.M., Neale, M.C. & Prescott, C.A. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch. Gen. Psychiatry 57, 261–269 (2000).
Reich, T. et al. Genome-wide search for genes affecting the risk for alcohol dependence. Am. J. Med. Genet. 81, 207–215 (1998).
Long, J.C. et al. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am. J. Med. Genet. 81, 216–221 (1998).
Thomasson, H.R. et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am. J. Hum. Genet. 48, 677–681 (1991).
Chen, Y.-C. et al. Alcohol metabolism and cardiovascular response in an alcoholic patient homozygous for the ALDH2*2 variant gene allele. Alcohol. Clin. Exp. Res. 23, 1853–1860 (1999).
Crabbe, J.C., Phillips, T.J., Buck, K.J., Cunningham, C.L. & Belknap, J.K. Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends Neurosci. 22, 173–179 (1999).
Crawley, J.N. et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132, 107–124 (1997).
Brodkin, E.S. et al. Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents: initial studies in Lewis and Fischer 344 rats and in A/J and C57BL/6J mice. Brain Res. 805, 55–68 (1998).
Berrettini, W.H., Ferraro, T.N., Alexander, R.C., Buchberg, A.M. & Vogel, W.H. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nature Genet. 7, 54–58 (1994).
McBride, W.J. & Li, T.K. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit. Rev. Neurobiol. 12, 339–369 (1998).
Mogil, J.S. et al. The genetics of pain and pain inhibition. Proc. Natl Acad. Sci. USA 93, 3048–3055 (1996).
Weiss, K.M. & Terwilliger, J.D. How many diseases does it take to map a gene with SNPs? Nature Genet. 26, 151–157 (2000).
Burmeister, M. Basic concepts in the study of diseases with complex genetics. Biol. Psychiatry 45, 522–532 (1999).
Nestler, E.J., Berhow, M.T. & Brodkin, E.S. Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol. Psychiatry 1, 190–199 (1996).
Würbel, H. Behaviour and the standardization fallacy. Nature Genet. 26, 263 (2000).
Gerlai, R. Molecular genetic analysis of mammalian behavior and brain processes: caveats and perspectives. Sem. Neurosci. 8, 153–161 (1996).
Berridge, K.C. & Robinson, T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Rev. 28, 309–369 (1998).
Wolf, M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679–720 (1998).
Kalivas, P.W. & Nakamura, M. Neural systems for behavioral activation and reward. Curr. Opin. Neurobiol. 9, 223–227 (1999).
Tzschentke, T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56, 613–672 (1998).
Koob, G.F., Sanna, P.P. & Bloom, F.E. Neuroscience of addiction. Neuron 21, 467–476 (1998).
Wise, R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51, 13–22 (1998).
Everitt, B.J. et al. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann. NY Acad. Sci. 877, 412–438 (1999).
Shaham, Y., Erb, S. & Stewart, J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Rev. 33, 13–33 (2000).
Rocha, B.A. et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393, 175–178 (1998).
Crabbe, J.C. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nature Genet. 14, 98–101 (1996).
Maldonado, R. et al. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273, 657–659 (1996).
Bohn, L.M. et al. Enhanced morphine analgesia in mice lacking b-arrestin 2. Science 286, 2495–2498 (1999).
Zhu, Y. et al. Retention of supraspinal d-like analgesia and loss of morphinemtolerance in d opioid receptor knockout mice. Neuron 24, 243–252 (1999).
Matthes, H.W. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the m-opioid receptor gene. Nature 383, 819–823 (1996).
Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. & Caron, M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606–612 (1996).
Ledent, C. et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401–404 (1999).
Rocha, B.A. et al. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci. 1, 132–137 (1998).
Maldonado, R. et al. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 586–589 (1997).
Zachariou, V., Caldarone, B.J., Weathers-Lowin, A. & Picciotto, M.R. Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology (in press).
Thiele, T.E., Marsh, D.J., Ste Marie, L., Bernstein, I.L. & Palmiter, R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396, 366–369 (1998).
Murtra, P., Sheasby, A.M., Hunt, S.P. & De Felipe, C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405, 180–183 (2000).
Horger, B.A. et al. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19, 4110–4122 (1999).
Messer, C.J. et al. Role of GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26, 247–257 (2000).
Bainton, R.J. et al. Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila. Curr. Biol. 10, 187–194 (2000).
McClung, C. & Hirsch, J. The trace amine tyramine is essential for normal sensitization to cocaine in Drosophila. Curr. Biol. 9, 853–860 (1999).
Andretic, R., Chaney, S. & Hirsh, J. A role for circadian genes in cocaine sensitization in Drosophila melanogaster. Science 285, 1066–1068 (1999).
Nestler, E.J. & Aghajanian, G.K. Molecular and cellular basis of addiction. Science 278, 58–63 (1997).
Kelz, M.B. et al. Expression of the transcription factor DFosB in the brain controls sensitivity to cocaine. Nature 401, 272–276 (1999).
Kelz, M.B. & Nestler, E.J. DFosB: A mediator of long-term neural plasticity. Curr. Opin. Neurol. (in press).
Whisler, K. et al. Effects of conditional over-expression of DFosB in nucleus accumbens on cocaine-seeking behavior. Soc. Neurosci. Abs. 25, 811 (1999).
Lane-Ladd, S.B. et al. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17, 7890–7901 (1997).
Carlezon, W.A. Jr et al. Regulation of cocaine reward by CREB. Science 282, 2272–2275 (1998).
Barrot, M., Neve, R.L & Nestler, E.J. Influence of CREB activity in nucleus accumbens shell on psychomotor and rewarding properties of morphine. Soc. Neurosci. Abs. 25, 35 (1999).
Kalivas, P.W., Duffy, P. & Mackler, S.A. Interrupted expression of NAC-1 augments the behavioral responses to cocaine. Synapse 33, 153–159 (1999).
Kuhar, M.J. & Dall Vechia, S.E. CART peptides: novel addiction- and feeding-related neuropeptides. Trends Neurosci. 22, 316–320 (1999).
Chen, J.S. et al. Induction of cyclin-dependent kinase 5 in hippocampus by chronic electroconvulsive seizures: role of DFosB. J. Neurosci. (in press).
About this article
Expression patterns of SLIT/ROBO mRNAs reveal a characteristic feature in the entorhinal-hippocampal area of macaque monkeys
BMC Research Notes (2020)
A Genetic Model of Impulsivity, Vulnerability to Drug Abuse and Schizophrenia-Relevant Symptoms With Translational Potential: The Roman High- vs. Low-Avoidance Rats
Frontiers in Behavioral Neuroscience (2019)
The loss of dopaminergic neurons in DEC1 deficient mice potentially involves the decrease of PI3K/Akt/GSK3β signaling
Dopamine D4 receptor gene expression plays important role in extinction and reinstatement of cocaine-seeking behavior in mice
Behavioural Brain Research (2019)